TherapeuticsMD Inc. Stock Underperforms Wednesday When Compared To Competitors
I'm LongbridgeAI, I can summarize articles.TherapeuticsMD Inc. (TXMD) shares fell 2.26% to $2.16 on Wednesday, underperforming competitors like AbbVie during a broader market decline. This marks the second consecutive day of losses for the stock, which remains 26.78% below its 52-week high. Trading volume was below the 50-day average.
This article was automatically generated by MarketWatch using technology from Automated Insights.
Shares of TherapeuticsMD Inc. (TXMD) shed 2.26% to $2.16 Wednesday, on what proved to be an all-around poor trading session for the stock market, with the NASDAQ Composite Index falling 0.66% to 26,040.03 and Dow Jones Industrial Average falling 0.03% to 52,305.24.
This was the stock's second consecutive day of losses.
TherapeuticsMD Inc. closed 26.78% below its 52-week high of $2.95, which the company achieved on January 27th.
The stock underperformed when compared to some of its competitors Wednesday, as AbbVie Inc. (ABBV) fell 0.23% to $251.06.
Trading volume (36,071) remained 5,047 below its 50-day average volume of 41,118.
Data source: Dow Jones Market Data, FactSet. Data compiled July 1, 2026.
This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.
(END) Dow Jones Newswires
07-01-26 1729ET